Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  ONO PHARMACEUTICAL CO., LTD.    4528   JP3197600004

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ( JPY)
Sales 2018 249 780 M
EBIT 2018 -
Net income 2018 45 583 M
Finance 2018 143 944 M
Yield 2018 1,90%
Sales 2019 270 050 M
EBIT 2019 -
Net income 2019 50 381 M
Finance 2019 158 150 M
Yield 2019 2,08%
P/E ratio 2018 27,32
P/E ratio 2019 23,48
EV / Sales2018 4,96x
EV / Sales2019 4,53x
Capitalization 1 381 762 M
More Financials
Company
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of pharmaceutical and diagnostic reagents focusing on prescription pharmaceuticals.Its products include respiratory, digestive, urinary, chemotherapy, hormone, vitamins, and metabolic drugs.The company was founded by Ichibei... 
Sector
Pharmaceuticals
Calendar
06/29Shareholder meeting
More about the company
Surperformance© ratings of ONO PHARMACEUTICAL CO., LT
Trading Rating : Investor Rating :
More Ratings
Latest news on ONO PHARMACEUTICAL CO., LT
05/25 ONO PHARMACEUTICAL : U.S. Food and Drug Administration Accepts for Priority Revi..
05/18 ONO PHARMACEUTICAL : Receives Supplemental Manufacturing and Marketing Approval ..
05/12 ONO PHARMACEUTICAL : Seikagaku and Ono Reach a Basic Agreement Related to Co-dev..
05/11 ONO PHARMACEUTICAL : Notice regarding Differences between Non-consolidated Resul..
05/08 ONO PHARMACEUTICAL : European Commission Approves Bristol-Myers Squibb’s O..
04/24 ONO PHARMACEUTICAL : Opdivo® (nivolumab) Designated for the Treatment of Biliary..
04/24 ONO PHARMACEUTICAL : Bristol-Myers Squibb Receives Positive CHMP Opinion Recomme..
04/06 ONO PHARMACEUTICAL : Numab and Ono Pharmaceutical Co., Ltd. Enter into a Researc..
04/06 ONO PHARMACEUTICAL : U.S. Food and Drug Administration Accepts for Priority Revi..
04/05 ONO PHARMACEUTICAL : Five-Year Survival Observed With Opdivo (nivolumab) in Pati..
More news
Sector news : Generic Pharmaceuticals
05/26DJSUN PHARMACEUTICAL INDUSTRIES : Pharma 4Q Profit Falls 13.6%
05/24 JOHNSON & JOHNSON : J&J settles drug manufacturing probe by U.S. states for $33 ..
05/24 FTSE edges up helped by M&S, but miners weigh
05/23DJMERCK : FDA OKs Merck's Keytruda to Treat Cancers With Genetic Defects -- Update
05/23DJMERCK : FDA Approves Merck's Keytruda to Treat Cancers With Genetic Defects
More sector news : Generic Pharmaceuticals
Latest Tweets
03/28Numab and Ono Pharmaceutical Co., Ltd. Enter into a Research and Option Agree.. 
02/06ONO PHARMACEUTICAL : Certain Media Coverage Related to ONO Reported on Februa.. 
01/20BRIEF-Bristol-Myers squibb and Ono pharmaceutical enters license agreement wi.. 
2016BRIEF-Ligand enters into worldwide OmniAb platform license agreement with ONO.. 
2016Ligand Pharmaceuticals : Enters into Worldwide OmniAb® Platform License Agree.. 
More tweets
Qtime:15
News from SeekingAlpha
05/10 BRISTOL-MYERS SQUIBB : A Deep Dive Finds Some Pearls
01/23 Bristol Catches A Break At Last
2016 Opdivo's price halved in Japan
2016 Bristol's Bid To Get Ahead In Head And Neck
2016 A European Biotech Stock Basket For 2016 - Update
Advertisement
Chart ONO PHARMACEUTICAL CO., LT
Duration : Period :
ONO PHARMACEUTICAL CO., LT Technical Analysis Chart | 4528 | JP3197600004 | 4-Traders
Full-screen chart
Technical analysis trends ONO PHARMACEUTICA...
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 14
Average target price 2 736  JPY
Spread / Average Target 17%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Gyo Sagara President & Representative Director
Shozo Matsuoka Executive Officer & Manager-Medical Affairs
Kazuhito Kawabata Director & Managing Executive Officer
Hiroshi Awata Director, EVP & General Manager-Development
Isao Ono Director & Managing Executive Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ONO PHARMACEUTICAL CO...-8.34%12 404
OTSUKA HOLDINGS CO LTD-0.77%25 309
SUN PHARMACEUTICAL IND..-10.03%21 115
SHANGHAI FOSUN PHARMAC..34.10%10 966
ASPEN PHARMACARE HOLDI..4.00%10 475
TAISHO PHARMACEUTICAL ..-9.68%7 097
More Results